What Is 18q deletion syndrome

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 14, 2026

Quick Answer: 18q deletion syndrome is a rare genetic disorder caused by the deletion of part of the long arm of chromosome 18, affecting approximately 1 in 55,000 live births. Symptoms include developmental delays, intellectual disability, and congenital abnormalities such as heart defects and cleft palate.

Key Facts

18q deletion syndrome affects about 1 in 55,000 newborns worldwide
The deletion occurs on the long arm (q) of chromosome 18, typically between bands 18q21 and 18q23
Over 90% of cases are de novo, meaning they are not inherited from either parent
Common physical features include midface hypoplasia, deep-set eyes, and hand or foot abnormalities
About 70% of individuals with the syndrome experience moderate to severe hearing loss

Overview

18q deletion syndrome is a chromosomal disorder resulting from the partial loss of genetic material on the long arm of chromosome 18. This condition leads to a wide range of developmental, neurological, and physical challenges, with severity varying significantly between individuals based on the size and location of the deletion.

First described in 1964 by Finnish geneticist Lauri Salla, the syndrome has since been studied in over 300 documented cases. While rare, it is one of the more frequently diagnosed microdeletion syndromes due to advances in chromosomal microarray analysis and genetic screening techniques.

Chromosome 18: The deletion occurs specifically on the long arm (q) of chromosome 18, most commonly in the region between bands 18q21 and 18q23, disrupting critical developmental genes.
Incidence rate: The syndrome affects approximately 1 in 55,000 live births, making it one of the rarer chromosomal disorders but increasingly identified due to improved genetic testing.
Developmental delays: Nearly all individuals experience delays in motor skills, speech, and cognitive development, often requiring early intervention and special education services.
Physical characteristics: Common features include midface hypoplasia, deep-set eyes, a small jaw, and foot deformities such as clubfoot or overlapping toes.
Medical complications: Up to 60% of patients have congenital heart defects, including ventricular septal defects or tetralogy of Fallot, requiring surgical correction in infancy.

How It Works

The syndrome arises from a structural abnormality during gamete formation or early embryonic development, leading to loss of genetic material critical for normal growth and neurological function.

Genetic mechanism: The deletion removes between 2 and 20 million base pairs of DNA, affecting multiple genes including MBP, CTDP1, and TCF4, which are vital for brain and nerve development.
De novo mutations: Over 90% of cases are not inherited but occur spontaneously, meaning parents typically have normal chromosomes and recurrence risk is low.
Diagnosis method: Identified via chromosomal microarray analysis (CMA) or fluorescence in situ hybridization (FISH), which can detect the missing segment with high precision.
Gene impact: Loss of the MBP gene leads to hypomyelination in the central nervous system, contributing to motor delays and neurological deficits.
Variable expression: Because deletion sizes vary, symptoms range from mild learning disabilities to severe intellectual disability and life-threatening medical issues.
Endocrine involvement: About 40% of individuals develop growth hormone deficiency, leading to short stature and requiring hormone replacement therapy.

Comparison at a Glance

Below is a comparison of 18q deletion syndrome with other common chromosomal disorders:

Syndrome	Chromosome Affected	Incidence	Key Features	Inheritance Pattern
18q Deletion	18q	1 in 55,000	Developmental delay, hearing loss, hypomyelination	Mostly de novo
Down Syndrome	21	1 in 700	Intellectual disability, heart defects, flat facial profile	Trisomy 21 (usually de novo)
Williams Syndrome	7q11.23	1 in 7,500	Hypercalcemia, cardiovascular disease, overly friendly personality	Deletion, mostly de novo
Prader-Willi Syndrome	15q11-q13	1 in 10,000–30,000	Obesity, hypotonia, insatiable hunger	Paternal deletion or imprinting defect
DiGeorge Syndrome	22q11.2	1 in 4,000	Heart defects, immune deficiency, cleft palate	Autosomal dominant (50% inherited)

While 18q deletion syndrome is much rarer than conditions like Down or DiGeorge syndrome, it shares overlapping features such as congenital heart defects and cleft palate. However, its unique genetic profile and hypomyelination distinguish it clinically, requiring specialized diagnostic and therapeutic approaches.

Why It Matters

Understanding 18q deletion syndrome is critical for early diagnosis, intervention, and improving long-term outcomes for affected individuals and their families. As genetic testing becomes more accessible, timely identification allows for coordinated care across neurology, cardiology, and developmental specialties.

Early intervention: Children who receive physical and speech therapy before age 2 show significantly better developmental progress and communication skills.
Genetic counseling: Families benefit from genetic counseling to understand recurrence risks and reproductive options, especially in rare inherited cases.
Hearing management: With 70% experiencing hearing loss, regular audiological screening is essential to support language development.
Educational support: Most children require individualized education plans (IEPs) to address learning disabilities and cognitive challenges.
Medical monitoring: Lifelong surveillance for endocrine, neurological, and orthopedic issues improves quality of life and prevents complications.
Research advancements: Ongoing studies on TCF4 and MBP genes may lead to targeted therapies for myelination and cognitive function.

As awareness grows and genetic technologies improve, 18q deletion syndrome is becoming less of a diagnostic mystery and more of a manageable condition with the right support systems in place.